Funding Rounds
Eligo Bioscience

Eligo Bioscience Series B (2023, $30M)

Eligo Bioscience

Gene-editing platform.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →